148 related articles for article (PubMed ID: 38406822)
1. Occupational daily walking steps have inverse relationship with papillary thyroid cancer risk and progression: a retrospective analysis.
Zhang C; Zhang L; Su Y; Xiang L; Zhang Q; Zhang C; Huan Q
Int J Occup Med Environ Health; 2024 Mar; 37(1):58-71. PubMed ID: 38406822
[TBL] [Abstract][Full Text] [Related]
2. Inverse Relationship of BMI to TSH and Risk of Papillary Thyroid Cancer in Surgical Patients.
Handelsman RS; Alvarez AL; Picado O; Farrá JC; Lew JI
J Surg Res; 2019 Dec; 244():96-101. PubMed ID: 31280000
[TBL] [Abstract][Full Text] [Related]
3. Hyperinsulinemia and thyroid peroxidase antibody in Chinese patients with papillary thyroid cancer.
Guo X; Chen X; Zhang C; Zhang J; Zhang C
Endocr J; 2019 Aug; 66(8):731-737. PubMed ID: 31118347
[TBL] [Abstract][Full Text] [Related]
4. Fasting serum glucose, thyroid-stimulating hormone, and thyroid hormones and risk of papillary thyroid cancer: A case-control study.
Hu MJ; Zhang C; Liang L; Wang SY; Zheng XC; Zhang Q; Jiang CX; Zhong Q; Huang F
Head Neck; 2019 Jul; 41(7):2277-2284. PubMed ID: 30759328
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.
Wu X; Lun Y; Jiang H; Gang Q; Xin S; Duan Z; Zhang J
Endocrine; 2014 Aug; 46(3):554-60. PubMed ID: 24338678
[TBL] [Abstract][Full Text] [Related]
7. Thyroid-Stimulating Hormone, Thyroid Hormones, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study.
Huang H; Rusiecki J; Zhao N; Chen Y; Ma S; Yu H; Ward MH; Udelsman R; Zhang Y
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1209-1218. PubMed ID: 28377419
[No Abstract] [Full Text] [Related]
8. Impaired thyroid hormone sensitivity increases the risk of papillary thyroid cancer and cervical lymph node metastasis.
Muhanhali D; Deng L; Ai Z; Ling Y
Endocrine; 2024 Mar; 83(3):659-670. PubMed ID: 37668929
[TBL] [Abstract][Full Text] [Related]
9. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
10. Association of Body Mass Index With Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study.
Dong Z; Liu W; Su F; Cheng R
Endocr Pract; 2023 Feb; 29(2):83-88. PubMed ID: 36481471
[TBL] [Abstract][Full Text] [Related]
11. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
[TBL] [Abstract][Full Text] [Related]
12. Positive Thyroid Peroxidase Antibody and Thyroglobulin Antibody are Associated With Better Clinicopathologic Features of Papillary Thyroid Cancer.
Li L; Shan T; Sun X; Lv B; Chen B; Liu N; Zhang B; Hu S; Zeng Q; Turner AG; Sheng L
Endocr Pract; 2021 Apr; 27(4):306-311. PubMed ID: 33645517
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
[TBL] [Abstract][Full Text] [Related]
14. IS IT WORTH SUPPRESSING TSH IN LOW- AND INTERMEDIATE-RISK PAPILLARY THYROID CANCER PATIENTS BEFORE THE FIRST DISEASE ASSESSMENT?
Lamartina L; Montesano T; Falcone R; Biffoni M; Grani G; Maranghi M; Ciotti L; Giacomelli L; Ramundo V; Lomonaco C; Di Gioia CR; Piernatale L; Ronga G; Durante C
Endocr Pract; 2019 Feb; 25(2):165-169. PubMed ID: 30383494
[TBL] [Abstract][Full Text] [Related]
15. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
[TBL] [Abstract][Full Text] [Related]
16. High Iodine Nutrition May Be a Risk Factor for Cervical Lymph Node Metastasis in Papillary Thyroid Cancer Patients.
Fan L; Tian Q; Xiu C; Wang F; Yuan Z; He Q; Guo L; Sun Q; Yang X; Miao S; Sun J; Sun D
Ann Nutr Metab; 2021; 77(2):90-99. PubMed ID: 34289482
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes.
Ni Y; Wang T; Wang X; Tian Y; Wei W; Liu Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):225-232. PubMed ID: 36161301
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A1 is negatively associated with male papillary thyroid cancer patients: a cross-sectional study of single academic center in China.
Ma M; Wang M; Zhang Z; Lin B; Sun Z; Guan H; Lv W; Li J
BMC Endocr Disord; 2021 Apr; 21(1):69. PubMed ID: 33853556
[TBL] [Abstract][Full Text] [Related]
19. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Miccoli P; Grasso L; Pinchera A; Vitti P
Endocr Relat Cancer; 2010 Mar; 17(1):231-9. PubMed ID: 20167722
[TBL] [Abstract][Full Text] [Related]
20. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
